Top Companies in Pharma Industry
Pharmaceutical Industry












Aventis Pharma Limited

In May 1956, Aventis Pharma Limited was established as Hoechst Fedco Pharma Private Ltd. With 50.1% holding of paid-up share capital, Sanofi-aventis is the major shareholder of Aventis Pharma Ltd.

Aventis is currently present in over 100 countries with its global headquarters in Paris, France. The total employee strength worldwide is about 100,000, including 11000 scientists. Product portfolio of Aventis includes medicines in the area of cardiovascular disease, thrombosis, diabetes, bone disease, epilepsy and cancer. It has 20 research centers in three continents, with R&D budget of about 4 billion euros.
Aventis Pharma Ltd. India has 2 state-of-art manufacturing facilities at Ankleshwar (Gujarat) and at Verna (Goa). These sites have been identified as the global sourcing units.

The company is working to bring innovative products so as to make the necessary treatments more widely available. In India it has employee strength of about 1840.

Corporate Address
Aventis House

54/A, Sir Mathuradas Vasanji Road,
Andheri (E),
Mumbai - 400 093
India.
Ph: 91-22-28278000
Fax: 91-22-28370939

Quarterly Results of Aventis

Quarterly Results (Rs.in Millions)

 

Dec 2006

(3 rd quarter)

Sept 2006

(2nd quarter)

Dec 2005

(3 rd quarter)

Sales Turnover

2572

2364

2375

Other Income

156

90

78

Total Income

2728

2454

2453

Total Expenditure

1885

1745

1656

Operating Profit

843

709

797

Interest

0

1

0

Gross Profit

843

708

797

Depreciation

43

42

43

Tax

262

227

257

*Source: economictimes.indiatimes.com

Quarterly Results (in %)

 

% Change (Over Sep 2006)

% Change (Over Dec 2005)

Sales Turnover

8.8

8.29

Other Income

73.33

100

Total Income

11.17

11.21

Total Expenditure

8.02

13.83

Operating Profit

18.9

5.77

Interest

-100

0

Gross Profit

19.07

5.77

Depreciation

2.38

0

Tax

 

 

Reported PAT

22.55

8.25

*Source: economictimes.indiatimes.com  

Annual Results of Aventis

Annual Unaudited Results (Rs. in Millions)

 

(12 Months)

(12 Months)

% Changes

Sales Turnover

8,581.00

7,864.00

9.12

Other Income

295

218

35.32

Total Income

8,876.00

8,082.00

9.82

Total Expenditure

6,340.00

5,719.00

10.86

Operating Profit

2,536.00

2,363.00

7.32

Interest

0

1

-100

Gross Profit

2,536.00

2,362.00

7.37

Depreciation

172

168

2.38

Tax

913

777

17.5

Reported PAT

1,451.00

1,485.00

-2.29

*Source: economictimes.indiatimes.com